Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis

B Bo Zhang R Runbo Zhong C Chunlei Shi T Tianqing Chu W Wei Zhang H Huimin Wang X Xin Gan Z Zhihong Zhang C Changbin Zhu X Xing Li (Interdisciplinary Science Center, State Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology) W Wenzhong Su J Juan Li Y Yanwei Zhang B Baohui Han H Hua Zhong (Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543, Republic of Singapore)

Article Details

Volume / Issue Vol. 17, Issue 1
Published May 25, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (15)

B

Bo Zhang

R

Runbo Zhong

C

Chunlei Shi

T

Tianqing Chu

W

Wei Zhang

H

Huimin Wang

X

Xin Gan

Z

Zhihong Zhang

C

Changbin Zhu

X

Xing Li

Interdisciplinary Science Center, State Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology

W

Wenzhong Su

J

Juan Li

Y

Yanwei Zhang

B

Baohui Han

H

Hua Zhong

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543, Republic of Singapore